Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Praziquantel; Pyrantel embonate
Bayer Animal Health GmbH
QP52AA51
Praziquantel; Pyrantel embonate
30.0/345.0 mg/tablet
Tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
praziquantel, combinations
Authorised
2009-03-20
Health Products Regulatory Authority 19 June 2020 CRN009RF9 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Big Cat Wormer Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCES Pyrantel embonate 345 mg Praziquantel 30 mg EXCIPIENTS Titanium dioxide E171 (colouring agent) 2.60 mg For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet. White to yellowish, round, biconvex tablet, unscored. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of gastrointestinal roundworms and tapeworms: _Toxocara cati, Toxascaris leonina, Dipylidium caninum, _ _Taenia taenaeformis._ 4.3 CONTRAINDICATIONS Do not use simultaneously with piperazine compounds. Not intended for use in kittens less than 6 weeks of age. Do not use during pregnancy. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Fleas serve as intermediate hosts for one common type of tapeworm – _Dipylidium caninum._ Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken. As a precautionary measure to prevent the establishment of _E. multilocularis _in the UK or Ireland, it is recommended that all cats entering the country be treated with praziquantel. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None known. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS In the interests of good hygiene, persons administering the tablets directly to a cat, or by adding them to the cat’s food, should wash their hands afterwards. Any part-used tablets should be discarded Health Products Regulatory Authority 19 June 2020 CRN009RF9 Page 2 of 4 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Mild and transient digestive tract disorders such as hyperthyroidism and/or vomiting and mild and transient neurological disorders such as ataxia may occur in extremely rare case Read the complete document